• Cartesian Therapeutics issued an inducement stock option for 6,100 common shares to a new employee on June 8, 2026.
• Exercise price set at USD 5.86 per share, matching the Nasdaq closing price on the grant date.
• Vesting starts with 25% on June 8, 2027, then monthly installments through June 8, 2030; option term is 10 years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cartesian Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606121605PRIMZONEFULLFEED9735107) on June 12, 2026, and is solely responsible for the information contained therein.